J David Enloe Jr's Net Worth
$653 Thousand
Who is J David Enloe Jr?
J David Enloe Jr does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Societal CDMO, Inc., and INTROGEN THERAPEUTICS INC.
SEC CIK
J David Enloe Jr's CIK is 0001201526
Past Insider Trading and Trends
2022 was J David Enloe Jr's most active year for acquiring shares with 14 total transactions. J David Enloe Jr's most active month to acquire stocks was the month of December. 2007 was J David Enloe Jr's most active year for disposing of shares, totalling 3 transactions. J David Enloe Jr's most active month to dispose stocks was the month of December. 2023 saw J David Enloe Jr paying a total of $50,000.00 for 976,290 shares, this is the most they've acquired in one year. In 2023 J David Enloe Jr cashed out on 88,031 shares for a total of $119,152.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Societal CDMO, Inc. (SCTL) Snapshot price: $0.4739
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.67M |
$1.10 | -$2,933,527.30 |
0
|
Apr 8
| |||
Form 4
| +105.87% | 1.37M |
—
|
—
| 2.67M |
Feb 29
| |||
Form 4
| +17.88% | 196.47K |
—
|
—
| 1.3M |
Jan 24
| |||
Form 4
| +12.83% | 125K |
$0.40 | $50,000.00 | 1.1M |
Aug 28
| |||
Form 4
| +95.55% | 475.88K |
$1.35 | -$119,152.31 | 973.94K |
Jan 19 - Jan 20
| |||
Form 4
| -2.24% | -11.41K |
$1.33 | -$15,179.29 | 498.06K |
Dec 15
| |||
Form 4
| +0.13% | 660 |
$1.71 | $1,128.60 | 509.47K |
Scheduled
|
Nov 15
| ||
Form 4
| +0.12% | 625 |
$1.69 | $1,056.25 | 508.81K |
Scheduled
|
Oct 17
| ||
Form 4
| +0.14% | 714 |
$1.41 | $1,006.74 | 508.18K |
Scheduled
|
Sep 15
| ||
Form 4
| +0.15% | 757 |
$1.26 | $953.82 | 507.47K |
Scheduled
|
Aug 15
| ||
Form 4
| +0.23% | 1.15K |
$0.81 | $930.81 | 506.71K |
Scheduled
|
Jul 15
| ||
Form 4
| +0.31% | 1.56K |
$0.68 | $1,062.16 | 505.56K |
Scheduled
|
Jun 15
| ||
Form 4
| +0.22% | 1.09K |
$0.96 | $1,043.65 | 504K |
Scheduled
|
May 16
| ||
Form 4
| +0.12% | 625 |
$1.63 | $1,018.75 | 502.91K |
Scheduled
|
Apr 18
| ||
Form 4
| -4.31% | -22.59K |
$1.65 | -$37,273.50 | 501.21K |
Jan 20
| |||
Form 4
| +0.10% | 512 |
$1.96 | $1,003.52 | 524.88K |
Scheduled
|
Mar 15
| ||
Form 4
| +0.11% | 571 |
$1.77 | $1,010.67 | 524.37K |
Scheduled
|
Feb 15
| ||
Form 4
| +238.46% | 369.04K |
—
|
—
| 523.8K |
Jan 20
| |||
Form 4
| +0.39% | 602 |
$1.68 | $1,011.36 | 154.76K |
Scheduled
|
Jan 18
| ||
Form 4
| +0.40% | 617 |
$1.61 | $993.37 | 154.16K |
Scheduled
|
Dec 15
| ||
Form 4
| +1.14% | 1.73K |
$1.68 | $2,895.24 | 153.54K |
Nov 12
| |||
Form 4
|
∞
| 151.81K |
—
|
—
| 151.81K |
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTROGEN THERAPEUTICS INC No price found
Sr. Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
∞
| 102.4K |
$0.66 | $67,180.80 | 102.4K |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +3,882.16% | 34.16K |
—
| $34.16 | 35.04K |
Mar 15 - May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
| No matching records found | |||||||||